You are here: Industry Insights > Novo Nordisk

News List

Novo Nordisk expands job cuts to 1,300 as executives play down Lilly’s GLP-1 threat fiercepharma
November 02, 2018
Diabetes giant Novo Nordisk has been slimming down this year, and now we know just how much. First it was 400 R&D jobs, then about 250 positions in the U.S., and now the company says it will have cut about 1,300 employees by the end of 2018.
Novo Nordisk leads pharma pack breaking into Reputation Institute’s corporate responsibility ranking fiercepharma
October 31, 2018
Big pharma’s reputation may be on the upswing, at least when it comes to corporate responsibility. Last year only Johnson & Johnson cracked the top 100 in Reputation Institute’s annual measurement of public perceptions.
Novo Nordisk boosts its GLP-1 score with yet more evidence for crucial semaglutide pill fiercepharma
October 29, 2018
Novo Nordisk rolled out its latest set of data for its next great hope: the oral version of semaglutide, which would become the only pill in the increasingly competitive GLP-1 class.
Say hello to Sophia, Novo Nordisk's new online chatbot, available 24/7 for diabetes questions fiercepharma
September 30, 2018
Novo Nordisk is hoping diabetes patients will "Ask Sophia," its first online chatbot, their questions and concerns regarding their condition.
Novo Nordisk announces plans to transform its approach to Research & Development worldpharmanews
September 30, 2018
Novo Nordisk announced plans to restructure its Research & Development (R&D) organisation to accelerate the expansion and diversification of its pipeline across serious chronic diseases. To enable increased investment in transformational biological and te
Novo Nordisk to slash 250 U.S. jobs in the face of ongoing pricing pressure fiercepharma
September 29, 2018
Days after swinging the ax on 400 R&D jobs in China and Denmark, diabetes giant Novo Nordisk is laying off again—this time in the U.S.
Novo Nordisk to lay off 400 employees in Denmark and China pharmaceutical-technology
September 25, 2018
Novo Nordisk has announced plans to lay off around 400 staff in research and development (R&D) roles at its China and Denmark sites as part of its R&D restructuring strategy.
Novo Nordisk to lay off 400 employees in Denmark and China pharmaceutical-technology
September 21, 2018
Novo Nordisk has announced plans to lay off around 400 staff in research and development (R&D) roles at its China and Denmark sites as part of its R&D restructuring strategy.
400 jobs to go as Novo Nordisk overhauls R&D operations pharmafile
September 20, 2018
Novo Nordisk has revealed its intention to restructure its research & development operations “to accelerate the expansion and...
Novo Nordisk announces plans to transform its approach to Research & Development worldpharmanews
September 20, 2018
Novo Nordisk announced plans to restructure its Research & Development (R&D) organisation to accelerate the expansion and diversification of its pipeline across serious chronic diseases.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page